Zobrazeno 1 - 10
of 74
pro vyhledávání: '"R S, Hermanides"'
Autor:
A. Selvarajah, A. H. Tavenier, W. L. Bor, V. Houben, S. Rasoul, E. Kaplan, K. Teeuwen, S. H. Hofma, E. Lipsic, G. Amoroso, M. A. H. van Leeuwen, J. M. ten Berg, A. W. J. van ‘t Hof, R. S. Hermanides
Publikováno v:
BMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Background Despite the advances of potent oral P2Y12 inhibitors, their onset of action is delayed, which might have a negative impact on clinical outcome in patients undergoing percutaneous coronary intervention (PCI). Trials conducted in th
Externí odkaz:
https://doaj.org/article/2bb6a0734614467a8d092ab71a67326a
Autor:
T. M. Hommels, R. S. Hermanides, B. Berta, E. Fabris, G. De Luca, E. H. Ploumen, C. von Birgelen, E. Kedhi
Publikováno v:
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-10 (2020)
Abstract Background Several studies compared everolimus-eluting bioresorbable scaffolds (EE-BRS) with everolimus-eluting stents (EES), but only few assessed these devices in patients with diabetes mellitus. Aim To evaluate the safety and efficacy out
Externí odkaz:
https://doaj.org/article/15ac810077b443b492d1c4aa9d883688
Autor:
T. M. Hommels, R. S. Hermanides, S. Rasoul, B. Berta, A. J. J. IJsselmuiden, G. A. J. Jessurun, E. Benit, B. Pereira, G. De Luca, E. Kedhi
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-10 (2019)
Abstract Background Percutaneous coronary intervention (PCI) in patients with diabetes mellitus (DM) remains challenging even with modern drug-eluting stents (DES) due to high rates of repeat revascularization. Everolimus-eluting bioresorbable scaffo
Externí odkaz:
https://doaj.org/article/b6a1007823124237b68fd3352dbbb638
Autor:
W W Van Den Broek, M E Gimbel, R S Hermanides, C Runnet, R F Storey, D Austin, R M Oemrawsingh, J Cooke, G Galasko, R Walhout, D A A M Schellings, S H K The, M G Stoel, A W J Van 'T Hof, J M Ten Berg
Publikováno v:
European Heart Journal. 43
Background/Introduction Elderly constitute a large though specific group of patients presenting with non-ST elevation myocardial infarction (NSTEMI), as they are at higher risk of adverse cardiovascular events, as well as treatment-related complicati
Autor:
T.J.F. ten Cate, Yolande Appelman, D. J. van der Heijden, A. de Vos, A. W. J. van ’t Hof, S. Assa, Joop Jukema, P. Woudstra, M. L. J. van der Wielen, P. Damman, Reinier A. Waalewijn, Pieter-Jan Vlaar, Michiel Voskuil, W. Balder, Bastiaan Zwart, J. M. ten Berg, R. S. Hermanides, N. van Royen, Maarten A. Vink, F. Arslan, Jorrit S. Lemkes
Publikováno v:
Netherlands Heart Journal, 29(11), 557-565. BOHN STAFLEU VAN LOGHUM BV
Netherlands Heart Journal, 29(11), 557-565. Bohn Stafleu van Loghum
Netherlands Heart Journal, 29, 11, pp. 557-565
Netherlands Heart Journal, 29, 557-565
Arslan, F, Damman, P, Zwart, B, Appelman, Y, Voskuil, M, de Vos, A, van Royen, N, Jukema, J W, Waalewijn, R, Hermanides, R S, Woudstra, P, ten Cate, T, Lemkes, J S, Vink, M A, Balder, W, van der Wielen, M L J, Vlaar, P J, van der Heijden, D J, Assa, S, van ’t Hof, A W & ten Berg, J M 2021, ' 2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation : Recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groups ', Netherlands Heart Journal, vol. 29, no. 11, pp. 557-565 . https://doi.org/10.1007/s12471-021-01593-4
Netherlands Heart Journal, 29(11), 557-565. Bohn, Stafleu, Van Loghum
Netherlands Heart Journal, 29(11), 557-565. Bohn Stafleu van Loghum
Netherlands Heart Journal, 29, 11, pp. 557-565
Netherlands Heart Journal, 29, 557-565
Arslan, F, Damman, P, Zwart, B, Appelman, Y, Voskuil, M, de Vos, A, van Royen, N, Jukema, J W, Waalewijn, R, Hermanides, R S, Woudstra, P, ten Cate, T, Lemkes, J S, Vink, M A, Balder, W, van der Wielen, M L J, Vlaar, P J, van der Heijden, D J, Assa, S, van ’t Hof, A W & ten Berg, J M 2021, ' 2020 ESC Guidelines on acute coronary syndrome without ST-segment elevation : Recommendations and critical appraisal from the Dutch ACS and Interventional Cardiology working groups ', Netherlands Heart Journal, vol. 29, no. 11, pp. 557-565 . https://doi.org/10.1007/s12471-021-01593-4
Netherlands Heart Journal, 29(11), 557-565. Bohn, Stafleu, Van Loghum
Contains fulltext : 245649.pdf (Publisher’s version ) (Open Access) Recently, the European Society of Cardiology (ESC) has updated its guidelines for the management of patients with acute coronary syndrome (ACS) without ST-segment elevation. The cu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00577884155eadd23224b917d0b8d9c6
https://link.springer.com/content/pdf/10.1007/s12471-021-01593-4.pdf
https://link.springer.com/content/pdf/10.1007/s12471-021-01593-4.pdf
Autor:
Saman Rasoul, A. W. J. van ’t Hof, Rudolf T Tolsma, E. Kedhi, R. S. Hermanides, J. P. Ottervanger, Robbert J. Slingerland, Anne H. Tavenier, S. van Workum
Publikováno v:
Netherlands Heart Journal
Netherlands Heart Journal, 27(4), 185-190. Bohn Stafleu van Loghum
Netherlands Heart Journal, 27(4), 185-190. Bohn Stafleu van Loghum
Background Fast and accurate platelet inhibition is an important therapeutic goal in the acute treatment of patients with ST-elevation myocardial infarction (STEMI). Platelet inhibitory effects induced by oral P2Y12-receptor antagonists are delayed i
Autor:
A.W.J. van't Hof, Vincent Roolvink, A. T. M. Gosselink, Harry Suryapranata, Erik A Badings, J.H.E. Dambrink, E van 't Riet, R. S. Hermanides, J. P. Ottervanger, E. Kedhi, Wouter Remkes, A Van Der Sluis
Publikováno v:
Netherlands Heart Journal, 27, 2, pp. 73-80
Netherlands Heart Journal, 27, 73-80
Netherlands Heart Journal, 27(2), 73-80. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands Heart Journal, 27, 73-80
Netherlands Heart Journal, 27(2), 73-80. Bohn Stafleu van Loghum
Netherlands Heart Journal
Contains fulltext : 202710.pdf (Publisher’s version ) (Open Access) BACKGROUND: An early invasive strategy (EIS) is recommended in high-risk patients with non-ST-elevation acute coronary syndrome (NSTE-ACS), defined as coronary angiography (CAG), w
Autor:
D A A M Schellings, M Neufang, G Captur, J Schaap, R S Hermanides, C Riedel, W L Bor, S G Mazzilli, J L van Doorn, J P van Meerbeeck, M F L Meijs, J Trauth, I. C. C. van der Horst, E J Meijer, A Friedrichs, J Redon, C A Biolé, K Hellwig, E Tessitore, F J F Broeyer, Bryan Williams, C Degenhardt, M Caputo, Gerry P McCann, A Moriarty, Azfar Zaman, R M M Gevers, C E Delsing, A G Er, A J M van Boxem, E Lensink, O V Blagova, D F Mesitskaya, R S Patel, E Saneei, A N Alnafie, N Y Y Al-Windy, Marijke Linschoten, M von Bergwelt-Baildon, E Wierda, K Jourdan, Angela C. Shore, M Tajdini, S E van der Kooi, R. Macias Ruiz, S Grangeon, A Guclu, Abdullah M. Alshehri, A G M Zondag, T Veneman, L Eberwein, Chiara Bucciarelli-Ducci, M Broekman, M. van Smeden, K Wille, R M A van de Wal, T E Alling, P H M Westendorp, A. van Lingen, R Pisters, W R M Hermans, A Aujayeb, K Elshinawy, M Milovanovic, A.G. Raafs, E Vlieghe, I C D Westendorp, L E Zijlstra, Michiel T H M Henkens, B Cosyns, Robert M. Bell, A J Moss, J A Offerhaus, K van Aken, A L Groenendijk, I M J Drost, M Worm, C P M van Nes, R Strauss, C Weytjens, M J G T Vehreschild, A Mosterd, D Rauschning, N C Lea, J M Kwakkel-van Erp, S Handgraaf, M E Emans, J. De Sutter, H P A A van Veen, M G Perrelli, N Knufman, S Borgmann, H Poorhosseini, P Woudstra, R J Thomson, R Ahmed, M Alshahrani, J T Drost, F Dormal, L I Veldhuis, D O Verschure, F V Y Tjong, Bas L.J.H. Kietselaer, M J Forner, M Bos, A C Reidinga, P Messiaen, A M Willems, H Bleijendaal, D P Ripley, J.K. de Vries, J Rüddel, J Seelig, C Ball, E P A van Iperen, S Rieg, M W J van Hessen, N T B Scholte, J B Ferreira, F S van den Brink, S E Jansen, P den Boer-Penning, G L ten Kate, B A S Koole, S Dolff, C Piepel, C Spinner, M Kochanek, J. M. ten Berg, R Salah, M Z H Kolk, A Shafiee, N Charlotte, P van der Meer, B Jensen, J Schubert, M Hower, A F M Kuijper, R A Tio, L Kuipers-Elferink, L Montagna, P M van der Zee, D Heigener, Lucia S.D. Jewbali, N H Sturkenboom, M Saxena, R Byrom-Goulthorp, E A W de Bruijn, J Nattermann, N A Haenen, A M Persoon, M Bontje, M Stecher, Fahad Al-Muhanna, C M Kievit, E Hellou, S Reinders, A van Poppel, Y A Almubarak, J Lanznaster, P Timmermans, P van Doorn, Luis Romao, K Hosseini, F Hanses, M Bianco, C Römmele, Stephane Heymans, R L Anthonio, F M A C Martens, L Tometten, J. Vom Dahl, D J van der Heijden, L Bosch, P Dark, C A Den Uil, A J Melein, A H Ruiter, P R Nierop, M Maarse, N M Cardoso, H Heidbuchel, M Alkhalil, W Guggemos, S K Zoet-Nugteren, A Dunnink, P Kleikers, M M Rüthrich, D Lomas, L Pilgram, J T Kielstein, S Williams, B C T van Bussel, A Pieterse-Rots, J Domange, S Nadalin, F M A Paris, H A M van Kesteren, E A Badings, C Anning, E C E Bayraktar-Verver, J Huisman, M Magro, S Bruinsma, E.M. Van Craenenbroeck, U Merle, F J Bermúdez Jiménes, D H van Dalen, L Tercedor Sanchez, M van der Graaf, M M J M van der Linden, N Isberner, Folkert W. Asselbergs, Amein K. Al-Ali, A. Van Der Sluis, E A van Beek, S H van Ierssel, H G R Dorman, R Zaal, A M Wils, Yigal M. Pinto, I Lemoine, B C Pölkerman, V van Marrewijk, A Habib, P C Smits, B E Groenemeijer, M J Reitsma, E McFarlane, R G Tieleman, M Hendriks-van Woerden, J L Selder, L Walter, Alicia Uijl, H J Siebelink, I Voigt, Gerard C.M. Linssen, H Vial, Mark T. Kearney, D J van de Watering, H E Vonkeman, J W M van Eck, B Grüner, D G Gognieva, P Markart, K Hamilton, C E E van Ofwegen-Hanekamp, A Janssen, C Raichle, A I C Sousa, W. H. Van Gilst, B Hedayat, L Gabriel, S Stieglitz, K W Wu, P Vreugdenhil, K Rothfuss, M A C Koole, T Westhoff, S Prasad, C M Van De Heyning, A M H Koning, T A C de Vries, A M Al-Rubaish, A D Hilt, E Parker, E Dekimpe, C E M Jakob, M I A Ribeiro, B M Hessels-Linnemeijer, P S Monraats, M J van Kempen, W Hermans-van Ast, F J H Magdelijns, K K Kui, H E Haerkens-Arends, P Y Kopylov, A Schut, T C Jacobs, P van der Harst
AimsPatients with cardiac disease are considered high risk for poor outcomes following hospitalization with COVID-19. The primary aim of this study was to evaluate heterogeneity in associations between various heart disease subtypes and in-hospital m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039e6ff95fab722a1bc19b17c5e21666
https://doi.org/10.1101/2021.03.11.21253106
https://doi.org/10.1101/2021.03.11.21253106
Autor:
Willem Dewilde, Cornelis Boersma, Emanuele Barbato, Richard M. Tjon Joe Gin, Gerrit J.A. Vos, R. S. Hermanides, Pim van der Harst, Jean-Paul R. Herrman, Vera H.M. Deneer, Carmine Morisco, Arend Mosterd, Maarten J. Postma, Danny M Claassens, Folkert W. Asselbergs, Thomas O. Bergmeijer, Arnoud W J van 't Hof, Jurriën M. ten Berg
Publikováno v:
Circulation. 142
Introduction: The POPular Genetics trial demonstrated that a genotype-guided strategy to select antiplatelet therapy in patients with ST-elevation myocardial infarction (STEMI) compared to universal treatment with ticagrelor or prasugrel, resulted in
Autor:
Fernando Alfonso, E. Kedhi, F Kauer, G. De Luca, Tomasz Roleder, Wojtek Wojakowski, Balázs Berta, W Kennedy, R. S. Hermanides, Alexander Ijsselmuiden, Javier Escaned
Publikováno v:
European Heart Journal. 41
Background Effect of statin therapy on coronary plaque stabilisation and reducing adverse cardiovascular events is well known both in primary and secondary prevention. Nevertheless, there is a paucity of data presenting the impact of statins on plaqu